Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709641 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion
A NA study, sponsored by John C Meyer, MD.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03709641 is a NA study that has completed, run by John C Meyer, MD. The registered enrollment target is 14 participants.
The verdict
NCT03709641, a NA study, has completed, sponsored by John C Meyer, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
A study which participants with mild to moderate dry eye disease will have a punctum of one eye injected with Restyalne Defyne and the other eye injected with saline solution. Participants will be evaluated over four visits.
Interventions
- DEVICE Restylane Defyne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-10-17 |
| Est. Completion | 2018-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709641
The ClinicalTrials.gov registry entry for NCT03709641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John C Meyer, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane Defyne is the first listed.
NCT03709641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03709641 about?
NCT03709641 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion". A study which participants with mild to moderate dry eye disease will have a punctum of one eye injected with Restyalne Defyne and the other eye injected with saline solution. Participants will be evaluated over four visits.
What is the current status of trial NCT03709641?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-10-17. Estimated completion is 2018-11-28.
What interventions are being tested in trial NCT03709641?
The interventions under investigation include: Restylane Defyne (DEVICE).
Who is sponsoring clinical trial NCT03709641?
This trial is sponsored by John C Meyer, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.